Clinical Trial Update: A Clinical Trial to Assess the Safety and Immunogenicity of New Malaria Vaccine Candidates ChAd63 Pfs25-IMX313 and MVA Pfs25-IMX313 [Phase 1]

View source ↗

Summary

An update on a Phase 1 trial evaluating the safety and immunogenicity of two malaria vaccine candidates, ChAd63 Pfs25-IMX313 and MVA Pfs25-IMX313. The study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malaria

Drugs mentioned

• ChAd63 Pfs25-IMX313
• MVA Pfs25-IMX313

Snippet

Sponsor: University of Oxford | Conditions: Malaria | Phase 1 | Status: COMPLETED